Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 7.60p
   
  • Change Today:
      0.000p
  • 52 Week High: 14.90
  • 52 Week Low: 7.40
  • Currency: UK Pounds
  • Shares Issued: 500.00m
  • Volume: 972,957
  • Market Cap: £38.00m
  • Beta: 0.80

Latest ShareCast News

Poolbeg Pharma granted new US patent

By Josh White

Date: Wednesday 20 Nov 2024

(Sharecast News) - Clinical-stage biopharmaceutical company Poolbeg Pharma announced on Wednesday that it has been granted a US patent for its 'Immunomodulator I' application.

Poolbeg agrees 12-month option over potential Behcet's treatment

By Josh White

Date: Tuesday 30 Apr 2024

(Sharecast News) - Poolbeg Pharma announced an exclusive 12-month option agreement with Silk Road Therapeutics on Tuesday, to potentially acquire a novel topical muco-adherent formulation of Pentoxifylline (tPTX).

Poolbeg Pharma to be granted US patent

By Josh White

Date: Wednesday 20 Mar 2024

(Sharecast News) - Biopharmaceutical company Poolbeg Pharma announced on Wednesday that it has received a notice of allowance from the US Patent Office regarding its immunomodulator II patent application.

Director dealings: Poolbeg Pharma co-founder ups... 19-Feb-2024 ShareCast
Poolbeg upbeat on research into potential drug m... 12-Feb-2024 ShareCast
Poolbeg makes promising progress with RSV progra... 20-Dec-2023 ShareCast
Poolbeg gets notice of a new Japan patent 20-Sep-2023 ShareCast
Poolbeg reports progress with oral vaccine devel... 22-Jun-2023 ShareCast
Poolbeg expands its focus molecule into oncology 16-Jan-2023 ShareCast
Poolbeg identifies new drug candidates with OneT... 21-Dec-2022 ShareCast
Poolbeg secures exclusive licence to possible ob... 14-Dec-2022 ShareCast
Poolbeg announces 'breakthrough' in AI drug targ... 08-Nov-2022 ShareCast
Poolbeg Pharma upbeat on US patent application p... 04-Oct-2022 ShareCast
Poolbeg inks exclusive deal for melioidosis vacc... 21-Sep-2022 ShareCast
Poolbeg granted European patent for antiviral no... 14-Apr-2022 ShareCast
Poolbeg signs option deal for potential melioido... 06-Dec-2021 ShareCast
Poolbeg adds Daniel Hoft to scientific advisory ... 25-Nov-2021 ShareCast
New patents filed to protect Poolbeg disease pre... 14-Oct-2021 ShareCast
 
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 7.60p
Change Today 0.000p
% Change 0.00 %
52 Week High 14.90
52 Week Low 7.40
Volume 972,957
Shares Issued 500.00m
Market Cap £38.00m
Beta 0.80

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
61.63% below the market average61.63% below the market average61.63% below the market average61.63% below the market average61.63% below the market average
36% below the sector average36% below the sector average36% below the sector average36% below the sector average36% below the sector average
Price Trend
59.16% below the market average59.16% below the market average59.16% below the market average59.16% below the market average59.16% below the market average
18.37% below the sector average18.37% below the sector average18.37% below the sector average18.37% below the sector average18.37% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:37 30,000 @ 7.60p
16:03 30,000 @ 7.60p
16:03 30,000 @ 7.60p
15:59 6,443 @ 7.76p
15:59 300 @ 7.75p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page